DUX4 and facioscapulohumeral muscular dystrophy: To that end, PMO-mediated approaches are being investigated in facioscapulohumeral muscular dystrophy (FSHD) by targeting the polyadenylation signal region of the double homeobox 4 (DUX4) transcript, destabilizing the transcript and reducing its aberrant expression.5